![David Robinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Robinson
Corporate Officer/Principal bij
OCULAR THERAPEUTIX, INC.
Vermogen: 613 554 $ op 31-05-2026
Profiel
David W.
Robinson is the Global Chief Commercial Officer at Ocular Therapeutix, Inc. starting in 2026.
Former positions include Secretary, Co-CEO & General Counsel at Glowpoint, Inc. from 2009 to 2010; VP-Sales, Field Access & Reimbursement at Regeneron Pharmaceuticals, Inc.; Chief Marketing Officer-Global Ophthalmology at Merck & Co., Inc.; VP & GM-Immunology Business Unit at UCB, Inc.; and Vice President & General Counsel at Con Edison Communications from 2001 to 2006.
Education includes undergraduate degrees from Appalachian State University and the University of Pennsylvania, and a graduate degree from Boston College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-06-2026 | 68.097 ( 0,03% ) | 613 554 $ | 31-05-2026 |
Actieve functies van David Robinson
| Bedrijven | Functie | Begin |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Corporate Officer/Principal | 21-01-2026 |
Eerdere bekende functies van David Robinson
| Bedrijven | Functie | Einde |
|---|---|---|
Con Edison Communications
 Con Edison Communications Specialty TelecommunicationsCommunications Provides telecommunication services | Algemeen Adviseur | 17-03-2006 |
| REGENERON PHARMACEUTICALS, INC. | Verkoop & Marketing | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | - |
| OBLONG INC. | President | - |
Opleiding van David Robinson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
13
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Glowpoint, Inc.
 Glowpoint, Inc. Specialty TelecommunicationsCommunications Provides cloud and managed visual communication solutions | Communications |
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Con Edison Communications
Con Edison Communications Specialty TelecommunicationsCommunications Provides telecommunication services | Communications |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Appalachian State University
 Appalachian State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
